Literature DB >> 17461565

Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.

Lutz Franke1, Oliver Schwarz, Lutz Müller-Kuhrt, Christina Hoernig, Lutz Fischer, Sven George, Yusuf Tanrikulu, Petra Schneider, Oliver Werz, Dieter Steinhilber, Gisbert Schneider.   

Abstract

A natural product collection and natural-product-derived combinatorial libraries were virtually screened for potential inhibitors of human 5-lipoxygenase (5-LO) activity. We followed a sequential ligand-based approach in two steps. First, similarity searching with a topological pharmacophore descriptor (CATS 2D method) was performed to enable scaffold-hopping. Eighteen compounds were selected from a virtual hit list of 430 substances, which had mutual pharmacophore features with at least one of 43 known 5-LO inhibitors that served as query structures. Two new chemotypes exhibited significant activity in a cell-based 5-LO activity assay. The two most potent molecules served as seed structures for a second virtual screening round. This time, a focused natural-product-derived combinatorial library was analyzed by different ligand-based virtual screening methods. The best molecules from the final set of screening candidates potently suppressed 5-LO activity in intact cells and may represent a novel class of 5-LO inhibitors. The results demonstrate the potential of natural-product-derived screening libraries for hit and lead structure identification.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17461565     DOI: 10.1021/jm060655w

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Discovery of new Mycobacterium tuberculosis proteasome inhibitors using a knowledge-based computational screening approach.

Authors:  Rukmankesh Mehra; Reena Chib; Gurunadham Munagala; Kushalava Reddy Yempalla; Inshad Ali Khan; Parvinder Pal Singh; Farrah Gul Khan; Amit Nargotra
Journal:  Mol Divers       Date:  2015-08-01       Impact factor: 2.943

2.  On the interpretation and interpretability of quantitative structure-activity relationship models.

Authors:  Rajarshi Guha
Journal:  J Comput Aided Mol Des       Date:  2008-09-11       Impact factor: 3.686

3.  Inhibitors of SARS-3CLpro: virtual screening, biological evaluation, and molecular dynamics simulation studies.

Authors:  Prasenjit Mukherjee; Falgun Shah; Prashant Desai; Mitchell Avery
Journal:  J Chem Inf Model       Date:  2011-05-23       Impact factor: 4.956

Review 4.  Classification of scaffold-hopping approaches.

Authors:  Hongmao Sun; Gregory Tawa; Anders Wallqvist
Journal:  Drug Discov Today       Date:  2011-10-26       Impact factor: 7.851

5.  Novel human mPGES-1 inhibitors identified through structure-based virtual screening.

Authors:  Adel Hamza; Xinyun Zhao; Min Tong; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  Bioorg Med Chem       Date:  2011-08-25       Impact factor: 3.641

Review 6.  Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors.

Authors:  Polamarasetty Aparoy; Kakularam Kumar Reddy; Pallu Reddanna
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

7.  Remodelling of the natural product fumagillol employing a reaction discovery approach.

Authors:  Bradley R Balthaser; Meghan C Maloney; Aaron B Beeler; John A Porco; John K Snyder
Journal:  Nat Chem       Date:  2011-12       Impact factor: 24.427

Review 8.  Building a virtual ligand screening pipeline using free software: a survey.

Authors:  Enrico Glaab
Journal:  Brief Bioinform       Date:  2015-06-20       Impact factor: 11.622

9.  Discovery of a natural product-like c-myc G-quadruplex DNA groove-binder by molecular docking.

Authors:  Dik-Lung Ma; Daniel Shiu-Hin Chan; Wai-Chung Fu; Hong-Zhang He; Hui Yang; Siu-Cheong Yan; Chung-Hang Leung
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.